Evidence map›Paper›PMID 15535849›Full record

ArticleBreast cancer research : BCR2004

Proteotypic classification of spontaneous and transgenic mammary neoplasms.

Igor Mikaelian, Natalie Blades, Gary A Churchill, Karen Fancher, Barbara B Knowles, Janan T Eppig, John P Sundberg

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Notch and its oncogenic activity in human malignancies.European surgery : ACA : Acta chirurgica Austriaca · 2017
    Review
  7. Article
  8. Mammary gland growth factors: roles in normal development and in cancer.Cold Spring Harbor perspectives in biology · 2010
    Review
  9. HUNK suppresses metastasis of basal type breast cancers by disrupting the interaction between PP2A and cofilin-1.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  10. Review
  11. Mammary cancer susceptibility: human genes and rodent models.Mammalian genome : official journal of the International Mammalian Genome Society · 2007
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Igor MikaelianThe Jackson Laboratory, Bar Harbor, Maine, USA. igor.mikaelian@roche.com
Natalie Blades
Gary A Churchill
Karen Fancher
Barbara B Knowles
Janan T Eppig
John P Sundberg
Jackson Laboratory · US

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
Mouse Models of Human Cancer DatabaseR01CA089713 · NCI · JACKSON LABORATORY · PI BULT, CAROL J · 2002 to 2025
$17.5M
EXPERIMENTAL DESIGN &ANALYSIS FOR EXPRESSION MICROARRAYR33CA088327 · NCI · JACKSON LABORATORY · PI CHURCHILL, GARY A · 2002 to 2003
$789k
EXPERIMENTAL DESIGN &ANALYSIS FOR EXPRESSION MICROARRAYR21CA088327 · NCI · JACKSON LABORATORY · PI CHURCHILL, GARY A · 2000 to 2001
$327k
NCI NIH HHS CA34196NCI NIH HHS CA88327NCI NIH HHS CA89713NCI NIH HHS P30 CA034196NCI NIH HHS R01 CA089713NCI NIH HHS R21 CA088327NCI NIH HHS R33 CA088327NCRR NIH HHS RR173
6 · The paper itself

Abstract

introductionMammary tumors in mice are categorized by using morphologic and architectural criteria. Immunolabeling for terminal differentiation markers was compared among a variety of mouse mammary neoplasms because expression of terminal differentiation markers, and especially of keratins, provides important information on the origin of neoplastic cells and their degree of differentiation.

methodsExpression patterns for terminal differentiation markers were used to characterize tumor types and to study tumor progression in transgenic mouse models of mammary neoplasia (mice overexpressing Neu (Erbb2), Hras, Myc, Notch4, SV40-TAg, Tgfa, and Wnt1), in spontaneous mammary carcinomas, and in mammary neoplasms associated with infection by the mouse mammary tumor virus (MMTV).

resultsOn the basis of the expression of terminal differentiation markers, three types of neoplasm were identified: first, simple carcinomas composed exclusively of cells with a luminal phenotype are characteristic of neoplasms arising in mice transgenic for Neu, Hras, Myc, Notch4, and SV40-TAg; second, 'complex carcinomas' displaying luminal and myoepithelial differentiation are characteristic of type P tumors arising in mice transgenic for Wnt1, neoplasms arising in mice infected by the MMTV, and spontaneous adenosquamous carcinomas; and third, 'carcinomas with epithelial to mesenchymal transition (EMT)' are a characteristic feature of tumor progression in Hras-, Myc-, and SV40-TAg-induced mammary neoplasms and PL/J and SJL/J mouse strains, and display de novo expression of myoepithelial and mesenchymal cell markers. In sharp contrast, EMT was not detected in papillary adenocarcinomas arising in BALB/cJ mice, spontaneous adenoacanthomas, neoplasms associated with MMTV-infection, or in neoplasms arising in mice transgenic for Neu and Wnt1.

conclusionsImmunohistochemical profiles of complex neoplasms are consistent with a stem cell origin, whereas simple carcinomas might originate from a cell committed to the luminal lineage. In addition, these results suggest that the initiating oncogenic events determine the morphologic features associated with cancer progression because EMT is observed only in certain types of neoplasm.

Indexed as

AnimalsBiomarkers, TumorCarcinomaCell DifferentiationDisease Models, AnimalDisease ProgressionEpithelial CellsFemaleImmunohistochemistryIntercellular Signaling Peptides and ProteinsKeratinsMammary Neoplasms, ExperimentalMiceMice, Inbred BALB CMice, Inbred C3HMice, TransgenicBiomarkers, TumorIntercellular Signaling Peptides and ProteinsKeratinsMyc protein, mouseProto-Oncogene Proteins c-mycWnt1 ProteinWnt1 protein, mouseWnt Proteins

Identifiers

PMID15535849
PMCPMC1064077
OpenAlexW2115750198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.